Unaudited Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents		$ 1,758	$ 1,263
Trade receivables - third party and affiliates		1,097	922
Non-trade receivables, net		583	545
Inventories		2,284	2,220
Assets held for sale		0	492
Other assets		247	251
Total current assets		5,969	5,693
Investments in affiliates		1,227	1,252
Property, plant and equipment, net		4,938	5,076
Operating lease right-of-use assets		376	359
Deferred income taxes		1,341	1,359
Other assets		608	601
Goodwill	[1]	4,157	4,171
Intangible assets, net		3,119	3,184
Total assets		21,735	21,695
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates		1,741	1,204
Trade payables - third party and affiliates		1,441	1,279
Liabilities held for sale		0	75
Other liabilities		1,040	1,049
Income taxes payable		94	76
Total current liabilities		4,316	3,683
Long-term debt, net of unamortized deferred financing costs		10,813	11,394
Deferred income taxes		512	512
Uncertain tax positions		225	208
Benefit obligations		332	344
Operating lease liabilities		275	265
Other liabilities		777	817
Commitments and Contingencies
Shareholders' Equity
Common stock, $0.0001 par value, 400,000,000 shares authorized (2026: 171,009,402 issued and 2025: 170,918,221 issued)		0	0
Treasury stock, at cost		(5,482)	(5,482)
Additional paid-in capital		439	431
Retained earnings		9,917	9,876
Accumulated other comprehensive income (loss), net		(811)	(776)
Total Celanese Corporation shareholders' equity		4,063	4,049
Noncontrolling interests		422	423
Total equity		4,485	4,472
Total liabilities and equity		$ 21,735	$ 21,695

[1] Includes accumulated impairment losses of $2.7 billion in the Engineered Materials segment.